Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Eureka 93 Inc LXLLF

Consumer Defensive Healthcare Household & Personal Products Drug Manufacturers - Specialty & Generic
Eureka 93 Inc is a Canada based company involved in hemp cultivation and CBD extraction operations in North America. The product offerings of the company include Wholesale CBD Products, Full Plant Extract and Isolate Powder.


GREY:LXLLF - Post by User

Eureka 93 Inc > Canopy reveals updated plan for CBD extraction, bye bye ERKA
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by thcforprofiton Apr 30, 2019 10:00am
61 Views
Post# 29688053

RE:RE:RE:Canopy reveals updated plan for CBD extraction, bye bye ERKA

RE:RE:RE:Canopy reveals updated plan for CBD extraction, bye bye ERKA$200k/day? Really?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities